Molecular genetics of human cervical cancer: Role of papillomavirus and the apoptotic cascade

Biological Chemistry

Volumn 385, Issue 8, 2004, Pages 671-682

  Ledwaba, Thokozile ^a   Dlamini, Zodwa ^a   Naicker, Sarala ^a   Bhoola, Kanti ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptotic signaling pathway; Cervical cancer therapy; Human cervical carcinoma; Human papillomavirus; Stem cell carcinogenesis

Indexed keywords

CANCER VACCINE; CAPSID PROTEIN; CASPASE; CASPASE 8; CELL SURFACE RECEPTOR; CONDYLOMA VACCINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLINE; CYTOCHROME C; DNA VACCINE; EPITOPE; HEAT SHOCK PROTEIN; INTERFERON REGULATORY FACTOR 1; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; POLYNUCLEOTIDE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADOPTIVE IMMUNOTHERAPY; APOPTOSIS; CANCER GENETICS; CANCER GROWTH; CANCER RISK; CELL COUNT; CONDYLOMA; CYTOGENETICS; DNA INTEGRATION; ENZYME ACTIVITY; FEMALE; GENETIC CODE; GENETIC REGULATION; HETEROZYGOSITY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFECTION RISK; MOLECULAR GENETICS; NONHUMAN; PAPILLOMA VIRUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; STEM CELL; T LYMPHOCYTE; UTERINE CERVIX CANCER; VIRUS CAPSID; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS ONCOGENE; VIRUS PARTICLE;

APOPTOSIS; CERVIX UTERI; FEMALE; HUMANS; ONCOGENES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, CELL SURFACE; RISK FACTORS; STEM CELLS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 4544303746     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.083     Document Type: Review

References (54)

1. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
2. Baege, A.C., Berger, A., Schlegel, R., Veldman, T., and Schlegel, R. (2002). Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in Htert gene expression and telomerase activity. Am. J. Pathol. 160, 1251-1257.
3. Basile, J.R., Zacny, V., and Munger, K. (2001). The cytokines tumor necrosis factor (TNF-alpha) and TNF related apoptosis- inducing ligand differentially modulate proliferation and apoptotic pathways in human papillomavirus 16E7 oncoprotein. J. Biol. Chem. 276, 22522-22528.
4. Brenna, S. M. F., Zeferino, L.C., Pinto, G.A., Souza, R.A., Andrande, L. A. L., Vassalo, J., Martinez, E.Z. and Syrjanen, K.J. (2002). C-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma. Braz. J. Med. Biol. Med. Res. 35, 425-430.
5. Butz, K., Denk, C., Ullmann, A., Scheffner, M., and Hoppe-Seyler, F. (2000). Induction of apoptosis in human pappillomavirus positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl. Acad. Sci. USA 97, 6693-6697.
6. Carr, J., and Gyorfi, T. (2000). Human papillomavirus: epidemiology, transmission and pathogenesis. Clin. Lab. Med. 20, 235-255.
7. Chakrabarti, O., and Krishna, S. (2003). Molecular interaction of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implication for tumor progression. J. Biosci. 28, 337-348
8. Chao, C., Sairo, S., Kang, J., Anderson, C.W., Appella, E., and Xu, Y. (2000). p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19, 4967-4975.
9. Chen, X.S., Garcea, R.L., Goldberg, I., Casini, G., and Harrison, S.C. (2000). Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5, 557-567.
10. Chene, P. (2003). Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 3, 102-109.
11. Chinnaiyan, A.M., and Dixit, V. M. (1996). The cell death machine. Curr. Biol 6, 555-562.
12. Cho, N.H., Lim, S.Y., Kim, Y.T., Kim, D., Kim, Y.S., and Kim, J.W. (2003). G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol. Oncol. 90, 15-22
13. Dasgupta, S., Chakraborty, B., Roy, A., Roychowdhury, S., Panda, C.K. (2003). Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol. Pathol. 56, 263-269.
14. Desaintes, C., Demeret, C., Goyat, S., Yaniv, M., and Thierry, F. (1997). Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16, 504-514.
15. Evan, G. and Littlewood, T. (1998). A matter of life and cell death. Science 281, 1317-1322.
16. Fausch, S.C., Da Silva, D.M., Rudolf, M.P., Kast, K.W. (2002). Human papillomavirus-like particles do not activate Langerhans cells: a possible immune escape mechamism used by human papillomaviruses. J. Immunol. 169, 3242-3249.
17. Filippova, M., Song, H., Connolly, J.L., Dermody, T.S., and Duerksen-Hughes, P.J. (2002). The human papillomavirus 16 E6 binds to tumour necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem 277, 21730-21739.
18. Finzer, P., Aguilar-Lemarroy, A., Rosl, F. (2002). The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett. 188, 15-24.
19. Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B., and Galloway, D.A. (1997). Inhibition of CDK activating and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV 16 E7 oncoprotein. Genes Dev. 11, 2090-2100.
20. Gao, Q., Kumar A., Srinivasan, S., Singh, L., Mukai, H., Ono, Y., Wazer, D.E. and Band, V. (2000). PKN binds and phosphorylates human papillomavirus E6 oncoprotein. J. Biol. Chem. 275, 14824-14830.
21. Goodwin, E.C., and DiMaio, D. (2001). Induced senescence in Hela cervical carcinoma cells containing elevated telomerase activity and extended telomeres. Cell Growth Differ. 12, 525-534.
22. Hagensee, M.E., Olson, N.H., Baker, T.S., and Galloway, D.A. (1994). Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J. Virol. 68, 4503-4505.
23. Hietanen, S., Lain, S., Krauz, E., Blattner, C., and Lane, D.P (2000). Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA 97, 8510-8506
24. Horikawa, I., and Barrett, J.C. (2003). Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanism. Carcinogenesis 24, 1167-1176.
25. Huh. J.J., Wolf, J.K., Fightmaster, D.L., Lotan, R., and Follen, M. (2003). Transduction of adenovirus mediated wild-type p53 after radiotherapy in human cervical cancer cells. Gynecol. Oncol. 89, 243-250.
26. Israels, L.G., and Israels, E.D. (1999). Apoptosis. Stem Cells 17, 306-313.
27. Janicek, M.F. and Averet, H.E. (2001). Cervical cancer: prevention, diagnosis and therapeutics. CA Cancer J. Clin. 51, 92-114.
28. Kabsch, K., and Alonso, A. (2002). The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J. Virol. 76, 12162-12172.
29. Kase, H., Aoki, Y., and Tanaka, K. (2003). Fas ligand expression in cervical adenocarcinoma relevance to lymph node metastasis and tumour progression. Gynecol. Oncol. 90, 70-74.
30. Kehmeier, E., Rühl, H., Voland, B., Stõppler, C.M., Androphy, E., and Stöppler, H. (2002). Cellular steady-state levels of 'high risk' but now 'low risk' human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53 and E6-AP binding capabilities. Virology 299, 72-87.
31. Kiechle, F.L., and Zhang, X. (2002). Apoptosis: biochemical aspects and clinical implications. Clin. Chim. Acta 326, 27-45.
32. Kiechle, F.L., and Zhang, X. (2002). Apoptosis: a brief review. J. Clin. Ligand Assay 21, 58-61.
33. Kim, K.Y., Seol, J.Y., Jeon, G., and Nam, M.J. (2003). The combined treatment of aspirin and radiation induces apoptosis by the regulation of Bcl-2 and caspase-3 in human cervical cancer cells. Cancer Lett. 189, 157-166.
34. Lee, D., Kim, H.Z., Jeong, K.W., Shim, Y.S., Horikawa, L., Barrett, J.C., and Choe, J. (2002). Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 277, 27748-27756.
35. Ma, Y.Y., Wei, S.J., Lin, Y.C., Lung, J.C., Chang, T.C., Whang-Peng J., Liu, J.M., Yang, D.M., Yang, W.K. and Shen, C.Y. (2000). PIKC3A as an oncogene in cervical cancer. Oncogene 19, 2739-2744.
36. Makin, G., and Dive, C. (2001). Apoptosis and cancer chemotherapy. Trends Cell Biol. 11, S22-26
37. Mantovani, F., and Banks, L. (1999). The interaction between p53 and papillomaviruses. Semin. Cancer Biol. 9, 387-395.
38. Matthews, C.P., Shera, K.A., and McDougall, J.K. (2000). Genomic changes and HPV type in cervical carcinoma. Proc. Soc. Exp. Biol. Med. 223, 316-321.
39. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
40. Oh, S.T., Kyo, S., and Laimins, L.A. (2001). Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through c-myc and GC rich Sp1m binding sites. J. Virol. 75, 5559-5566.
41. Park, I.K., Morrison, S.J. and Clarke, M.F. (2004). Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175-179.
42. Park, J., Boyer, S., Mitchell, K., Gilfor, D., Birrer, M., Darlington, G., El Deiry, W., Firestone, G.L., Munger, K., Band, V., Fisher, P.B., and Dent, P. (2000a). Expression of human papillomavirus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21. J. Biol. Chem. 275, 18-28.
43. Park, J., Kim, E.J., Kwon, H., Hwang, E.S., Namkoony, S.E., Um, S. (2000b). Inactivation of interferon regulatory factor-1 tumour suppressor protein by HPV E7 oncoprotein. J. Biol. Chem. 275, 6764-6769.
44. Patel, D., Huang, S., Baglia, L.A., and McCance, D.J (1999). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18, 5061-5072.
45. Pelicci, P.G. (2004). Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J. Clin. Invest. 113, 4-7.
46. Preston, S.L., Alison, M.R., Forbes, S.J., Direkze N.C., Poulsom, R. and Wright, N.A. (2003). The new stem biology: something for everyone. Mol. Pathol. 56, 86-96.
47. Scheffner, M., and Whitaker, N.J. (2003) Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13, 59-67.
48. Schiffman, M., and Castle, P.E. (2003). Human papillomavirus: epidemiology and public health. Arch. Pathol. Lab. Med. 127, 930-934.
49. Singh, B., Reddy, P.G., Goberdhan, A., Walsh, C., Dao, S., Ngai, I., Chou, T.C., O-Charoenrat, P., Levine, A.J., Rao, P.H., and Stoffel, A. (2002). p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinoma. Genes Dev. 16, 984-993.
50. Thompson, D.A., Zacny, V., Belinsky, G.S., Classon, M., Jones, D.L., Schlegel, R. and Munger, K. (2001). The HPV E7 oncoprotein inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts. Oncogene 20, 3629-3640.
51. Sharpless, N.E., and DePinho, R.A. (2004). Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160-168.
52. Tsai, R.Y. (2004). A molecular view of stem cell and cancer self-renewal. Int. J. Biochem. Cell Biol. 36, 684-694.
53. Tsujimoto, Y. (1997). Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ. 4, 429-434.
54. Veldman, T., Horikawa, I, Barrett, C.J., and Schlegel, R. (2001). Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75, 4467-4472.